The SCID-hu mouse: An in vivo model for HIV-1 infection in humans

Molecular Medicine Today

Volumn 3, Issue 6, 1997, Pages 246-253

  Bonyhadi, M L ^a   Kaneshima, H ^a  

^a CDR Therapeutics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CYCLAM DERIVATIVE; DIDANOSINE; NEVIRAPINE; ZIDOVUDINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; COMBINED IMMUNODEFICIENCY; DRUG SCREENING; GENE THERAPY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; NONHUMAN; REVIEW; T LYMPHOCYTE; THYMUS;

EID: 0031430862     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(97)01046-0     Document Type: Review

References (51)

1. Bosma G.C. Custer R.P. Bosma J.J. A severe combined immunodeficiency mutation in the mouse Nature 301 1983 527 530
2. Kaneshima H. Namikawa R. McCune J.M. Human hematolymphoid cells in SCID mice Curr. Opin. Immunol. 6 1994 327 333
3. McCune J.M. The SCID-hu mouse: a model for the analysis of human hematolymphoid differentiation and function Science 241 1988 1632 1639
4. Mosier D.E. Gulizia R.J. Baired S. Wilson D.B. Transfer of a functional human immune system to mice with severe combined immunodeficiency Nature 335 1988 256 259
5. McCune J. The SCID-hu mouse: a small animal model for HIV infection and pathogenesis Annu. Rev. Immunol. 9 1991 399 429
6. + T-cell depletion in Hu-PBL-SCID mice infected with different isolates of the human immunodeficiency virus J. Clin. Immunol. 15 1995 130S 133S
7. Namikawa R. Long-term human hematopoiesis in the SCID-hu mouse J. Exp. Med. 172 1990 1055 1063
8. Kyoizumi S. Implantation and maintenance of functional human bone marrow in SCID-hu mice Blood 79 1992 1704 1711
9. Kyoizumi S. Murray L.J. Namikawa R. Preclinical analysis of cytokine therapy in the SCID-hu mouse Blood 81 1993 1479 1488
10. Vandekerckhove B.A. Thymic selection of the human T cell receptor Vβ repertoire in SCID-hu mice J. Exp. Med. 176 1992 1619 1624
11. Baccala R. Bacterial superantigens mediate T cell deletions in the mouse severe combined immunodeficiency-human liver/thymus model J. Exp. Med. 177 1993 1481 1485
12. Komanduri K.V. Salha M-D. Sekaly R-P. McCune J.M. Superantigen-mediated deletion of specific T cell receptor Vβ subsets in the SCID-hu mouse is induced by staphylococcal enterotoxin B, but not HIV-1 J. Immunol. 158 1996 544 549
13. Krowka J.F. Human T cells in the SCID-hu mouse are phenotypically normal and functionally competent J. Immunol. 146 1991 3751 3756
14. Vandekerckhove B.A. Clonal analysis of the peripheral T cell compartment of the SCID-hu mouse J. Immunol. 146 1991 4173 4179
15. Vandekerckhove B.A. Namikawa R. Bacchetta R. Roncarolo M.G. Human hematopoietic cells and thymic epithelial cells induce tolerance via different mechanisms in the SCID-hu mouse thymus J. Exp. Med. 175 1992 1033 1043
16. DiGiusto D.L. Hematopoietic potential of cryopreserved and ex vivo manipulated umbilical cord blood progenitor cells evaluated in vitro and in vivo Blood 87 1996 1261 1271
17. − intermediate J. Exp. Med. 178 1993 265 277
18. Fraser C.C. Human allogeneic stem cell maintenance and differentiation in a long-term multilineage SCID-hu graft Blood 86 1995 1680 1693
19. Kollmann T.R. Disseminated human immunodeficiency virus 1 (HIV-1) infection in SCID-hu mice after peripheral inoculation with HIV-1 J. Exp. Med. 179 1994 513 522
20. Bonyhadi M.L. HIV induces thymus depletion in vivo Nature 363 1993 728 732
21. Aldrovandi G.M. The SCID-hu mouse as a model for HIV-1 infection Nature 363 1993 732 736
22. Mocarski E.S. Human cytomegalovirus in a SCID-hu mouse: thymic epithelial cells are prominent targets of viral replication Proc. Natl. Acad. Sci. U. S. A. 90 1993 104 108
23. + T-lymphocytes and epidermal cells in SCID-hu mice J. Virol. 69 1995 5236 5242
24. Auwearter P. Measles virus infection in the SCID-hu mouse: strain-dependent disruption of the human thymic microenvironment J. Virol. 70 1996 3734 3740
25. Schuurman H.J. The thymus in acquired immune deficiency syndrome: comparison with other types of immunodeficiency disease, and presence of components of human immunodeficiency virus type 1 Am. J. Pathol. 131 1989 1329 1334
26. Rosenzweig M. Human neonatal thymic organ culture: An ex vivo model of thymocyte ontogeny and HIV-1 infection Pathobiology 62 1994 245 251
27. Baskin G.B. Thymus in simian immunodeficiency virus-infected rhesus monkeys Lab. Invest. 65 1991 400 407
28. Beebe A.M. Primary stage of feline immunodeficiency virus infection: viral dissemination and cellular targets J. Virol. 68 1994 3080 3091
29. Kaneshima H. HIV-1-associated pathology in hemato-lymphoid organs and the experimental evaluation in the SCID-hu mouse Int. J. Hematol. 63 1996 253 264
30. Margolick J.B. Failure of T-cell homeostasis preceding AIDS in HIV-1 infection Nat. Med. 1 1995 674 680
31. Namikawa R. Infection of the SCID-hu mouse by HIV-1 Science 242 1988 1684 1686
32. McCune J.M. Suppression of HIV infection in AZT-treated SCID-hu mice Science 247 1990 564 566
33. Stanley S.K. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse J. Exp. Med. 178 1993 1151 1163
34. Su L. HIV-1 induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo Immunity 2 1995 25 36
35. Kaneshima H. Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in the human thymus of the SCID-hu mouse J. Virol. 68 1994 8188 8192
36. Su L. Identification of HIV-1 determinants for replication in vivo Virology 227 1996 45 52
37. Jamieson B.D. Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity J. Virol. 68 1994 3478 3485
38. Aldrovandi G.M. Zack J.A. Replication and pathogenicity of human immunodeficiency virus type 1 accessory gene mutants in SCID-hu mice J. Virol. 70 1996 1505 1511
39. Kaneshima H. Human immunodeficiency virus infection of human lymph nodes in the SCID-hu mouse Proc. Natl. Acad. Sci. U. S. A. 88 1991 4523 4527
40. Rabin L. Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds Antimicrob. Agents Chemother. 40 1996 755 762
41. Datema R. Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry Antimicrob. Agents Chemother. 40 1996 750 754
42. Akkina R.K. Modeling human lymphoid precursor cell gene therapy in the SCID-hu mouse Blood 84 1994 1393 1398
43. + cord blood cells is expressed by their T-cell progeny in the SCID-hu thymus Blood 88 1996 107 113
44. Plavec I. Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells Gene Ther. 3 1996 717 724
45. Bevec D. Dobrovnik M. Hauber J. Bohnlein E. Inhibition of human immunodeficiency virus type 1 replication in human T cells by retroviral-mediated gene transfer of a dominant-negative rev trans-activator Proc. Natl. Acad. Sci. U. S. A. 89 1992 9870 9874
46. Malim M.H. Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication J. Exp. Med. 176 1992 1197 1201
47. Su, L. et al. Hematopoietic stem cell-based gene therapy for AIDS: efficient transduction and expression of RevM10 in myeloid cells in vivo and in vitro , Blood (in press)
48. Feng Y. Broder C.C. Kennedy P.E. Berger E.A. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor Science 272 1996 872 877
49. Deng H. Identification of a major co-receptor for primary isolates of HIV-1 Nature 381 1996 661 666
50. + cells is mediated by the chemokine receptor CC-CKR-5 Nature 381 1996 667 673
51. Berson J.F. A seven-transmembrane domain receptor involved in fusion and entry of T-cell-tropic human immunodeficiency virus Type 1 strains J. Virol. 70 1996 6288 6295